Literature DB >> 2125559

Crystallization of prostaglandin-H synthase for X-ray structure analysis.

K Jahnke1, G H Degen, M Buehner.   

Abstract

Prostaglandin-H (PGH) synthase from ram seminal vesicles is a dimeric integral membrane protein of molecular weight 140 kDa. PGH synthase is a key enzyme in the biosynthesis of prostaglandins, has cyclooxygenase and peroxidase activities, and contains heme as a coenzyme. In the peroxidation step of its reaction. PGH synthase can use xenobiotics as co-substrates and can catalyze the metabolic activation of carcinogens such as diethylstilbestrol. To gain a detailed understanding of the inner workings of PGH synthase, we are investigating its three-dimensional structure by X-ray crystallography. A purification procedure was established that yields stable homogeneous PGH synthase that is at least 80% holoenzyme. The crucial aspect is the proper choice of type and concentration of detergent in all steps of the procedure. Single crystals can be obtained from concentrated solutions of PGH synthase in the presence of polyethylene glycol 4000 as a precipitant. Crystallization occurs during gas phase equilibration with a concentrated salt solution. The enzyme solution becomes turbid and forms a second liquid phase in which PGH synthase crystals grow up to 0.2 mm in length in the course of days. Manipulation of these crystals is very difficult due to the small volume of the growth phase. The crystals dissolved rapidly in all aqueous media into which they were transferred for mounting in X-ray capillaries. Therefore, we have not yet been able to demonstrate their true X-ray scattering power. A crystal provisionally dry mounted diffracted to about 8 A resolution.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125559      PMCID: PMC1567999          DOI: 10.1289/ehp.908833

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  9 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase).

Authors:  J P Merlie; D Fagan; J Mudd; P Needleman
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

3.  Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequence.

Authors:  C Yokoyama; T Takai; T Tanabe
Journal:  FEBS Lett       Date:  1988-04-25       Impact factor: 4.124

4.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

5.  Functional differentiation of cyclooxygenase and peroxidase activities of prostaglandin synthase by trypsin treatment. Possible location of a prosthetic heme binding site.

Authors:  L J Marnett; Y N Chen; K R Maddipati; P Plé; R Labèque
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

6.  Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthetase.

Authors:  G J Roth; E T Machuga; J Ozols
Journal:  Biochemistry       Date:  1983-09-27       Impact factor: 3.162

7.  Determination of the structure of the carbohydrate chains of prostaglandin endoperoxide synthase from sheep.

Authors:  J H Mutsaers; H van Halbeek; J P Kamerling; J F Vliegenthart
Journal:  Eur J Biochem       Date:  1985-03-15

8.  Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.

Authors:  D L DeWitt; W L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

Review 9.  Prostaglandin synthase-mediated metabolism of carcinogens and a potential role for peroxyl radicals as reactive intermediates.

Authors:  L J Marnett
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.